Matthias Mayerhofer

Matthias Mayerhofer

UNVERIFIED PROFILE

Are you Matthias Mayerhofer?   Register this Author

Register author
Matthias Mayerhofer

Matthias Mayerhofer

Publications by authors named "Matthias Mayerhofer"

Are you Matthias Mayerhofer?   Register this Author

50Publications

1799Reads

31Profile Views

Prominin-1 (CD133, AC133) and dipeptidyl-peptidase IV (CD26) are indicators of infinitive growth in colon cancer cells.

Am J Cancer Res 2015 15;5(2):560-74. Epub 2015 Jan 15.

Ludwig Boltzmann Cluster Oncology, Medical University of Vienna Waehringer Guertel 18-20, A-1090 Vienna, Austria ; Department of Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna Waehringer Guertel 18-20, A-1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396035PMC
May 2015

Identification of campath-1 (CD52) as novel drug target in neoplastic stem cells in 5q-patients with MDS and AML.

Clin Cancer Res 2014 Jul 5;20(13):3589-602. Epub 2014 May 5.

Authors' Affiliations: Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Austria; Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Austria;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-2811DOI Listing
July 2014

Polo-like kinase 1 (Plk1) as a novel drug target in chronic myeloid leukemia: overriding imatinib resistance with the Plk1 inhibitor BI 2536.

Cancer Res 2010 Feb 9;70(4):1513-23. Epub 2010 Feb 9.

Department of Internal Medicine I, Division of Hematology and Hemostaseology, Institute of Immunology, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, A-1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-09-2181DOI Listing
February 2010

Evaluation of in vivo antineoplastic effects of rapamycin in patients with chemotherapy-refractory AML.

Eur J Intern Med 2009 Dec 7;20(8):775-8. Epub 2009 Oct 7.

Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejim.2009.09.007DOI Listing
December 2009

Myeloid leukemias express a broad spectrum of VEGF receptors including neuropilin-1 (NRP-1) and NRP-2.

Leuk Lymphoma 2007 Oct;48(10):1997-2007

Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190701534424DOI Listing
October 2007

Eosinophilia in systemic mastocytosis: clinical and molecular correlates and prognostic significance.

J Allergy Clin Immunol 2007 Jul 23;120(1):192-9. Epub 2007 Apr 23.

Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaci.2007.03.015DOI Listing
July 2007

Detection of vascular endothelial growth factor (VEGF) and VEGF receptors Flt-1 and KDR in canine mastocytoma cells.

Vet Immunol Immunopathol 2007 Feb 17;115(3-4):320-33. Epub 2006 Nov 17.

Department for Small Animals and Horses, Clinic for Internal Medicine and Infectious Diseases, University of Veterinary Medicine Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vetimm.2006.11.009DOI Listing
February 2007

Immunohistochemical detection of histidine decarboxylase in neoplastic mast cells in patients with systemic mastocytosis.

Hum Pathol 2006 Apr 7;37(4):439-47. Epub 2006 Feb 7.

Division of Hematology and Hemostaseology, Department of Internal Medicine I, Medical University of Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2005.11.015DOI Listing
April 2006

PKC412 inhibits in vitro growth of neoplastic human mast cells expressing the D816V-mutated variant of KIT: comparison with AMN107, imatinib, and cladribine (2CdA) and evaluation of cooperative drug effects.

Blood 2006 Jan 27;107(2):752-9. Epub 2005 Sep 27.

Department of Internal Medicine I, Division of Hematology and Hemostaseology, Center of Excellence in Clinical and Experimental Oncology, Institute of Immunology, Medical University of Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2005-07-3022DOI Listing
January 2006

Transfusion-related exposure to the plasticizer di(2-ethylhexyl)phthalate in patients receiving plateletpheresis concentrates.

Transfusion 2005 May;45(5):798-802

Department of Blood Group Serology and Transfusion Medicine, the Institute for Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1537-2995.2005.04380.xDOI Listing
May 2005

Chronic myeloid leukemia: pathophysiology, diagnostic parameters, and current treatment concepts.

Wien Klin Wochenschr 2003 Aug;115(13-14):485-504

Abteilung für Hämatologie und Hämostaseologie, Universitätsklinik für Innere Medizin I, AKH-Wien, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/bf03041033DOI Listing
August 2003